AURION

Shares of Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a clinical-stage biopharmaceutical company that focuses in the field of nephrology and autoimmunity saw its stock soar by more than 35 percent Thursday morning. Aurinia announced Thursday morning data from a 24-week clinical study called...